— Know what they know.
Not Investment Advice

VREX NASDAQ

Varex Imaging Corporation
1W: +1.1% 1M: -16.6% 3M: -25.5% YTD: -13.1% 1Y: +24.4% 3Y: -54.2% 5Y: -57.7%
$10.07
-0.06 (-0.59%)
After Hours: $10.25 (+0.18, +1.84%)
Weekly Expected Move ±11.1%
$8 $9 $10 $11 $12
NASDAQ · Healthcare · Medical - Devices · Alpha Radar Strong Sell · Power 31 · $423.9M mcap · 41M float · 0.849% daily turnover · Short 44% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
54.3 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: -3.4%  ·  5Y Avg: 0.7%
Cost Advantage ★
69
Intangibles
67
Switching Cost
36
Network Effect
35
Scale
63
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. VREX shows a Weak competitive edge (54.3/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Cost Advantage. Negative ROIC of -3.4% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$14
Avg Target
$14
High
Based on 1 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 4Hold: 2Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$14.50
Analysts1
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-02-02 Jefferies Matthew Taylor $17 $14 -2 +2.3% $14.17
2024-05-28 Jefferies Matthew Taylor Initiated $17 +14.9% $14.79

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C+
May 22, 2026
DCF
4
ROE
1
ROA
1
D/E
1
P/E
1
P/B
4
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. VREX receives an overall rating of C+. Strongest factors: DCF (4/5), P/B (4/5). Areas of concern: ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5).
Rating Change History
DateFromTo
2026-05-12 B- C+
2026-05-08 C+ B-
2026-03-06 B- C+
2026-02-11 C+ B-
2026-01-16 B- C+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

16 Grade D
Profitability
14
Balance Sheet
51
Earnings Quality
50
Growth
35
Value
41
Momentum
37
Safety
30
Cash Flow
20
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. VREX scores highest in Balance Sheet (51/100) and lowest in Profitability (14/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
1.61
Distress Zone
Piotroski F-Score
4/9
Beneish M-Score
-2.92
Unlikely Manipulator
Ohlson O-Score
-6.34
Bankruptcy prob: 0.2%
Low Risk
Credit Rating
B
Score: 27.9/100
Trend: Deteriorating
Earnings Quality
OCF/NI: 0.02x
Accruals: -6.9%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. VREX scores 1.61, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. VREX scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. VREX's score of -2.92 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. VREX's implied 0.2% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. VREX receives an estimated rating of B (score: 27.9/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-5.12x
PEG
0.02x
P/S
0.50x
P/B
0.89x
P/FCF
-14.28x
P/OCF
EV/EBITDA
686.75x
EV/Revenue
0.80x
EV/EBIT
-26.31x
EV/FCF
-22.30x
Earnings Yield
-18.80%
FCF Yield
-7.00%
Shareholder Yield
0.34%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. VREX currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.101
NI / EBT
×
Interest Burden
2.877
EBT / EBIT
×
EBIT Margin
-0.030
EBIT / Rev
×
Asset Turnover
0.738
Rev / Assets
×
Equity Multiplier
2.307
Assets / Equity
=
ROE
-16.4%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. VREX's ROE of -16.4% is driven by Asset Turnover (0.738), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.10 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$10.07
Median 1Y
$7.54
5th Pctile
$3.32
95th Pctile
$17.15
Ann. Volatility
49.1%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Sunny S. Sanyal
President and Chief Executive Officer
$815,816 $2,662,978 $4,634,688
Shubham Maheshwari Financial
ancial Officer
$534,877 $781,974 $1,860,580
Kimberley E. Honeysett
Former SVP, CLO and Corporate Secretary
$420,908 $479,956 $1,266,317
Andrew J. Hartmann
SVP and General Manager, Detectors
$494,600 $443,963 $1,256,113
Mark S. Jonaitis
SVP and General Manager, X-Ray Sources
$405,908 $443,963 $1,184,198

CEO Pay Ratio

83:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $4,634,688
Avg Employee Cost (SGA/emp): $55,542
Employees: 2,400

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
2,400
+4.3% YoY
Revenue / Employee
$351,917
Rev: $844,600,000
Profit / Employee
$-29,292
NI: $-70,300,000
SGA / Employee
$55,542
Avg labor cost proxy
R&D / Employee
$37,958
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -3.9% 3.7% 5.4% 6.4% 5.5% 6.0% 6.3% 5.6% 5.8% 8.8% 8.1% 7.6% 6.2% -8.7% -8.6% -7.6% -24.0% -14.0% -13.4% -16.4% -16.41%
ROA -1.6% 1.5% 2.2% 2.6% 2.3% 2.6% 2.7% 2.4% 2.5% 4.0% 3.7% 3.4% 2.8% -3.9% -3.9% -3.4% -10.7% -6.0% -5.8% -7.1% -7.12%
ROIC 3.3% 5.8% 7.2% 7.5% 6.6% 6.9% 6.9% 6.2% 5.9% 14.2% 14.4% 15.3% 53.5% -37.6% -28.1% -16.6% -3.6% -3.1% -2.6% -3.4% -3.44%
ROCE 2.8% 7.2% 8.0% 9.0% 8.7% 8.0% 8.0% 7.1% 7.3% 5.4% 4.7% 4.1% 2.5% 2.9% 3.5% 4.8% -3.5% -2.6% -2.1% -2.8% -2.84%
Gross Margin 35.1% 33.4% 32.6% 33.0% 34.2% 32.2% 30.8% 31.9% 32.9% 34.3% 30.1% 31.9% 32.0% 32.6% 34.3% 36.0% 33.3% 34.0% 33.3% 33.6% 33.61%
Operating Margin 12.2% 11.7% 7.0% 12.4% 10.7% 10.6% 6.3% 6.8% 10.4% 10.7% 2.2% 3.7% 4.4% 5.3% 5.6% 10.4% -39.8% 8.6% 7.3% 6.7% 6.67%
Net Margin 5.7% 3.8% 0.7% 3.5% 3.8% 5.7% 1.5% 1.8% 3.9% 14.0% -0.3% 0.7% 0.7% -24.3% -0.2% 3.2% -43.9% 5.3% 1.1% -3.8% -3.75%
EBITDA Margin 16.3% 16.0% 10.7% 14.6% 14.4% 13.4% 9.9% 9.9% 14.0% 7.2% 7.3% 8.2% 6.5% 8.2% 8.9% 13.1% -35.0% 12.5% 10.6% 9.8% 9.81%
FCF Margin 1.8% 9.5% 9.7% 7.1% 4.2% -0.5% -2.3% 1.5% 5.9% 9.8% 11.0% 8.5% 5.1% 2.5% 3.1% 4.6% 4.4% 2.2% -1.6% -3.6% -3.59%
OCF Margin 4.0% 11.3% 11.5% 8.8% 5.9% 2.0% 0.3% 4.3% 8.7% 12.1% 13.9% 11.5% 8.2% 5.8% 5.7% 7.3% 7.3% 4.9% 1.9% -0.2% -0.23%
ROE 3Y Avg snapshot only -5.99%
ROE 5Y Avg snapshot only -1.30%
ROA 3Y Avg snapshot only -2.52%
ROIC 3Y Avg snapshot only -1.22%
ROIC Economic snapshot only -2.88%
Cash ROA snapshot only -0.18%
Cash ROIC snapshot only -0.28%
CROIC snapshot only -4.28%
NOPAT Margin snapshot only -2.88%
Pretax Margin snapshot only -8.76%
R&D / Revenue snapshot only 10.44%
SGA / Revenue snapshot only 15.81%
SBC / Revenue snapshot only 1.27%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -64.54 70.50 54.96 30.31 33.35 28.54 25.76 25.85 40.41 19.69 18.66 17.80 17.74 -10.20 -12.34 -10.09 -2.76 -7.10 -7.28 -5.32 -5.122
P/S Ratio 1.50 1.50 1.65 1.06 1.01 1.01 0.95 0.84 1.32 1.06 0.95 0.87 0.73 0.60 0.71 0.51 0.44 0.59 0.58 0.51 0.496
P/B Ratio 2.53 2.54 2.87 1.86 1.79 1.62 1.55 1.38 2.23 1.67 1.47 1.31 1.07 0.91 1.10 0.79 0.68 1.06 1.04 0.93 0.893
P/FCF 83.38 15.83 16.99 14.90 23.80 -196.51 -40.60 56.24 22.29 10.82 8.60 10.30 14.38 23.84 22.72 11.07 10.03 26.55 -37.05 -14.28 -14.284
P/OCF 37.83 13.25 14.38 11.97 17.14 51.16 343.41 19.39 15.15 8.75 6.80 7.59 8.86 10.28 12.60 7.07 6.12 11.97 30.61
EV/EBITDA 23.55 14.27 14.81 9.84 9.84 10.58 10.32 10.36 14.44 13.37 13.02 12.85 14.59 12.38 13.15 9.13 -73.85 233.09 97.32 686.75 686.750
EV/Revenue 2.00 1.88 2.02 1.43 1.38 1.41 1.35 1.23 1.71 1.37 1.26 1.19 1.06 0.93 1.04 0.84 0.77 0.88 0.87 0.80 0.801
EV/EBIT 55.50 21.80 21.71 13.79 13.83 14.98 14.55 15.05 20.80 20.97 21.64 22.75 32.45 25.21 24.04 14.25 -17.79 -31.08 -38.32 -26.31 -26.312
EV/FCF 111.41 19.89 20.86 20.11 32.47 -275.37 -57.69 82.72 28.80 13.97 11.45 14.11 20.92 37.07 33.18 18.12 17.45 39.68 -55.61 -22.30 -22.297
Earnings Yield -1.5% 1.4% 1.8% 3.3% 3.0% 3.5% 3.9% 3.9% 2.5% 5.1% 5.4% 5.6% 5.6% -9.8% -8.1% -9.9% -36.3% -14.1% -13.7% -18.8% -18.80%
FCF Yield 1.2% 6.3% 5.9% 6.7% 4.2% -0.5% -2.5% 1.8% 4.5% 9.2% 11.6% 9.7% 7.0% 4.2% 4.4% 9.0% 10.0% 3.8% -2.7% -7.0% -7.00%
PEG Ratio snapshot only 0.022
Price/Tangible Book snapshot only 1.691
EV/Gross Profit snapshot only 2.387
Shareholder Yield snapshot only 0.34%
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 3.25 3.33 3.33 3.33 3.33 3.52 3.52 3.52 3.52 4.04 4.04 4.04 4.04 3.32 3.32 3.32 3.32 3.43 3.43 3.43 3.428
Quick Ratio 1.56 1.98 1.98 1.98 1.98 1.77 1.77 1.77 1.77 2.34 2.34 2.34 2.34 1.97 1.97 1.97 1.97 1.83 1.83 1.83 1.829
Debt/Equity 1.07 0.95 0.95 0.95 0.95 0.82 0.82 0.82 0.82 0.83 0.83 0.83 0.83 0.88 0.88 0.88 0.88 0.85 0.85 0.85 0.850
Net Debt/Equity 0.85 0.65 0.65 0.65 0.65 0.65 0.65 0.65 0.65 0.49 0.49 0.49 0.49 0.50 0.50 0.50 0.50 0.52 0.52 0.52 0.522
Debt/Assets 0.43 0.40 0.40 0.40 0.40 0.37 0.37 0.37 0.37 0.38 0.38 0.38 0.38 0.39 0.39 0.39 0.39 0.36 0.36 0.36 0.363
Debt/EBITDA 7.48 4.25 4.00 3.72 3.83 3.81 3.84 4.17 4.11 5.13 5.52 5.91 7.77 7.70 7.23 6.19 -54.70 125.59 52.88 401.90 401.900
Net Debt/EBITDA 5.92 2.91 2.74 2.55 2.63 3.03 3.06 3.32 3.26 3.01 3.24 3.47 4.56 4.42 4.15 3.55 -31.38 77.12 32.47 246.80 246.800
Interest Coverage 0.60 1.68 1.88 2.06 2.05 2.02 2.14 2.14 2.39 2.03 1.98 1.69 0.99 1.07 1.12 1.43 -1.01 -0.68 -0.55 -0.62 -0.620
Equity Multiplier 2.52 2.37 2.37 2.37 2.37 2.22 2.22 2.22 2.22 2.20 2.20 2.20 2.20 2.27 2.27 2.27 2.27 2.34 2.34 2.34 2.343
Cash Ratio snapshot only 0.829
Debt Service Coverage snapshot only 0.024
Cash to Debt snapshot only 0.386
FCF to Debt snapshot only -0.077
Defensive Interval snapshot only 357.6 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.70 0.72 0.73 0.74 0.75 0.74 0.74 0.75 0.77 0.73 0.72 0.70 0.68 0.66 0.67 0.67 0.67 0.73 0.74 0.74 0.738
Inventory Turnover 1.99 2.20 2.26 2.28 2.29 2.18 2.21 2.26 2.31 2.08 2.04 1.99 1.95 2.04 2.04 2.02 2.00 1.96 1.99 2.02 2.020
Receivables Turnover 5.75 5.86 6.02 6.10 6.12 5.23 5.27 5.35 5.46 5.30 5.21 5.08 4.94 5.05 5.11 5.15 5.11 5.37 5.44 5.46 5.457
Payables Turnover 7.94 8.30 8.51 8.59 8.65 8.41 8.53 8.70 8.91 8.44 8.31 8.10 7.91 8.95 8.93 8.86 8.75 8.59 8.72 8.83 8.834
DSO 63 62 61 60 60 70 69 68 67 69 70 72 74 72 71 71 71 68 67 67 66.9 days
DIO 183 166 162 160 159 167 165 162 158 176 179 183 188 179 179 181 183 186 183 181 180.7 days
DPO 46 44 43 42 42 43 43 42 41 43 44 45 46 41 41 41 42 42 42 41 41.3 days
Cash Conversion Cycle 201 184 179 178 177 194 191 188 184 201 205 210 215 210 210 210 212 211 208 206 206.3 days
Fixed Asset Turnover snapshot only 4.581
Operating Cycle snapshot only 247.6 days
Cash Velocity snapshot only 5.529
Capital Intensity snapshot only 1.291
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue -1.2% 10.8% 17.4% 17.9% 12.1% 5.0% 3.1% 3.4% 5.0% 4.0% 1.3% -2.7% -7.2% -9.2% -6.5% -3.3% -1.4% 4.1% 4.1% 3.6% 3.63%
Net Income 24.4% 1.3% 1.4% 1.5% 2.5% 74.1% 27.0% -4.0% 13.5% 59.1% 39.4% 47.0% 16.3% -2.0% -2.1% -2.0% -4.9% -47.4% -42.5% -96.9% -96.90%
EPS 28.6% 1.3% 1.4% 1.5% 2.5% 85.2% 37.3% -0.0% -8.8% 28.8% 39.4% 44.5% 42.3% -2.2% -2.1% -1.8% -4.8% -43.9% -38.5% -1.4% -1.41%
FCF -37.4% 8.5% 4.6% 8.6% 1.6% -1.1% -1.2% -78.3% 46.8% 20.9% 5.8% 4.5% -20.8% -76.7% -73.3% -47.1% -13.7% -7.8% -1.5% -1.8% -1.80%
EBITDA 1.4% 26.1% 42.0% 18.3% 84.9% 6.0% -1.1% -15.3% -11.3% -20.0% -25.0% -24.0% -43.1% -33.3% -23.5% -4.4% -1.1% -94.8% -88.3% -98.7% -98.68%
Op. Income 8.5% 3.2% 3.5% 6.2% 1.6% 19.0% 6.3% -17.9% -14.1% -12.6% -21.7% -20.7% -41.2% -58.4% -42.8% -11.4% -1.8% -1.9% -1.6% -1.6% -1.59%
OCF Growth snapshot only -1.03%
Asset Growth snapshot only -9.01%
Equity Growth snapshot only -11.68%
Debt Growth snapshot only -14.56%
Shares Change snapshot only -18.16%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y -1.0% 1.9% 2.4% 3.1% 2.9% 3.3% 2.9% 3.4% 5.2% 6.6% 7.1% 5.8% 3.0% -0.3% -0.8% -0.9% -1.3% -0.6% -0.5% -0.8% -0.85%
Revenue 5Y 40.6% 21.3% 9.7% 3.9% 2.9% 2.7% 2.9% 2.3% 1.9% 1.2% 0.8% 0.6% 0.8% 1.3% 2.7% 3.6% 3.5% 3.51%
EPS 3Y -17.6% 4.6% 28.4% 47.7% 23.0% 39.4% 98.0%
EPS 5Y 12.1% -1.0% -7.1% -10.3% -11.3% -11.9% 5.9% 17.0% 25.1% 33.1%
Net Income 3Y -14.2% 9.5% 32.4% 50.5% 25.0% 41.9% 1.0%
Net Income 5Y 14.6% 0.2% -5.7% -9.2% -10.3% -7.0% 11.9% 18.4% 26.8% 35.1%
EBITDA 3Y -17.3% 5.5% 7.7% 12.7% 16.1% 11.9% 16.3% 17.5% 57.3% 1.3% -2.3% -17.3% -17.2% -14.9% -69.7% -59.4% -78.8% -78.78%
EBITDA 5Y 32.5% 18.4% 4.1% -0.5% -1.6% -1.5% -0.1% -1.5% -1.6% -4.6% -5.7% -2.0% 3.4% -31.0% -31.01%
Gross Profit 3Y -4.0% 2.3% 3.4% 5.0% 5.2% 3.4% 3.0% 4.2% 9.8% 15.1% 15.1% 12.8% 3.6% -1.8% -1.3% -0.7% -0.6% 0.8% 1.1% 0.4% 0.44%
Gross Profit 5Y 37.7% 19.4% 7.8% 1.9% 1.1% 1.0% 2.7% 2.4% 2.4% 1.8% 0.0% 0.8% 2.2% 5.3% 8.8% 9.4% 8.3% 8.28%
Op. Income 3Y -18.8% 18.5% 25.7% 34.0% 35.9% 24.5% 29.8% 41.7% 9.5% -24.3% -21.9% -16.8%
Op. Income 5Y 31.6% 18.2% 6.1% 1.9% 0.9% 3.6% 11.6% 10.6% 9.4% 4.9% -6.8% -0.4% 14.8%
FCF 3Y -36.6% 6.1% 22.8% 5.4% -9.6% -28.9% 34.5% 45.5% -35.9% -31.8% -14.1% 0.1%
FCF 5Y 37.9% -0.9% -27.8% -0.1% 6.2% 17.1% 7.0% -3.0% -17.1% -12.5% 1.0% 10.7%
OCF 3Y -28.2% 2.8% 13.9% 1.1% -9.3% -38.3% -68.2% -15.5% 17.8% 1.0% 1.2% 31.4% -20.1% -21.5% -7.3% 5.8% 35.1% 88.6%
OCF 5Y 40.4% 4.4% -21.1% -52.1% -15.3% -0.8% 4.9% 13.4% 6.2% 0.3% -8.0% -9.1% -0.9% 4.5% 25.9%
Assets 3Y 3.1% 5.1% 5.1% 5.1% 5.1% 4.4% 4.4% 4.4% 4.4% 3.1% 3.1% 3.1% 3.1% 2.0% 2.0% 2.0% 2.0% -2.2% -2.2% -2.2% -2.22%
Assets 5Y 13.0% 13.0% 2.6% 2.6% 2.6% 2.6% 4.8% 4.8% 4.8% 4.8% 3.2% 3.2% 3.2% 3.2% -0.6% -0.6% -0.6% -0.57%
Equity 3Y 6.0% 4.3% 4.3% 4.3% 4.3% 6.1% 6.1% 6.1% 6.1% 7.9% 7.9% 7.9% 7.9% 3.5% 3.5% 3.5% 3.5% -4.0% -4.0% -4.0% -3.95%
Book Value 3Y 3.5% 0.0% -0.4% 1.1% 2.4% 4.4% 4.3% 4.5% -2.5% -0.9% 6.6% 6.9% 8.0% 5.7% 5.7% -3.0% 2.6% -4.6% -5.3% -5.0% -5.04%
Dividend 3Y
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.93 0.13 0.05 0.70 0.75 0.85 0.60 0.44 0.55 0.70 0.52 0.49 0.44 0.31 0.27 0.22 0.16 0.32 0.46 0.46 0.460
Earnings Stability 0.74 0.29 0.25 0.14 0.18 0.05 0.04 0.03 0.00 0.10 0.15 0.21 0.52 0.00 0.00 0.01 0.11 0.06 0.06 0.11 0.106
Margin Stability 0.91 0.88 0.89 0.88 0.91 0.88 0.89 0.90 0.92 0.90 0.91 0.92 0.98 0.98 0.99 0.97 0.93 0.89 0.90 0.91 0.910
Rev. Growth Consistency 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.500
Earn. Growth Consistency 0.50 0.50 0.50 0.50 1.00 1.00 1.00 0.00 1.00 1.00 1.00 0.50 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 1 0 0 0 1 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 0
Earnings Persistence 0.50 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.50 0.50 0.84 0.81 0.93 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.500
Earnings Smoothness 0.46 0.76 0.96 0.87 0.54 0.67 0.62 0.85
ROE Trend -0.02 0.08 0.11 0.12 0.10 0.10 0.10 0.09 0.05 0.04 0.02 0.02 0.01 -0.16 -0.16 -0.14 -0.31 -0.15 -0.14 -0.17 -0.173
Gross Margin Trend 0.02 0.04 0.04 0.04 0.03 0.04 0.03 0.02 -0.01 -0.01 -0.01 -0.01 -0.00 -0.01 0.00 0.01 0.02 0.02 0.02 0.00 0.005
FCF Margin Trend -0.03 0.07 0.08 0.05 0.02 -0.05 -0.06 -0.02 0.03 0.05 0.07 0.04 -0.00 -0.02 -0.01 -0.00 -0.01 -0.04 -0.09 -0.10 -0.101
Sustainable Growth Rate 3.7% 5.4% 6.4% 5.5% 6.0% 6.3% 5.6% 5.8% 8.8% 8.1% 7.6% 6.2%
Internal Growth Rate 1.5% 2.3% 2.7% 2.3% 2.7% 2.8% 2.5% 2.6% 4.1% 3.8% 3.6% 2.9%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income -1.71 5.32 3.82 2.53 1.95 0.56 0.07 1.33 2.67 2.25 2.74 2.34 2.00 -0.99 -0.98 -1.43 -0.45 -0.59 -0.24 0.02 0.024
FCF/OCF 0.45 0.84 0.85 0.80 0.72 -0.26 -8.46 0.34 0.68 0.81 0.79 0.74 0.62 0.43 0.55 0.64 0.61 0.45 -0.83 15.40 15.400
FCF/Net Income snapshot only 0.372
OCF/EBITDA snapshot only -2.000
CapEx/Revenue 2.2% 1.8% 1.8% 1.7% 1.7% 2.5% 2.6% 2.8% 2.8% 2.3% 2.9% 3.0% 3.2% 3.3% 2.5% 2.6% 2.8% 2.7% 3.4% 3.4% 3.36%
CapEx/Depreciation snapshot only 1.063
Accruals Ratio -0.04 -0.07 -0.06 -0.04 -0.02 0.01 0.03 -0.01 -0.04 -0.05 -0.06 -0.05 -0.03 -0.08 -0.08 -0.08 -0.16 -0.10 -0.07 -0.07 -0.069
Sloan Accruals snapshot only -0.023
Cash Flow Adequacy snapshot only -0.069
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Total Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 0.1% 0.1% 0.0% 0.3% 0.3% 0.34%
Net Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 0.1% 0.1% -0.3% -0.0% -0.4% -0.41%
Total Shareholder Return 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 0.1% 0.1% -0.3% -0.0% -0.4% -0.41%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.06 0.61 0.69 0.63 0.57 0.68 0.69 0.70 0.66 1.54 1.76 2.12 9.77 -9.54 -5.86 -2.53 1.87 1.19 1.17 1.10 1.101
Interest Burden (EBT/EBIT) -0.61 0.40 0.47 0.53 0.53 0.55 0.58 0.57 0.60 0.54 0.49 0.44 0.13 0.17 0.23 0.34 1.98 2.47 3.00 2.88 2.877
EBIT Margin 0.04 0.09 0.09 0.10 0.10 0.09 0.09 0.08 0.08 0.07 0.06 0.05 0.03 0.04 0.04 0.06 -0.04 -0.03 -0.02 -0.03 -0.030
Asset Turnover 0.70 0.72 0.73 0.74 0.75 0.74 0.74 0.75 0.77 0.73 0.72 0.70 0.68 0.66 0.67 0.67 0.67 0.73 0.74 0.74 0.738
Equity Multiplier 2.43 2.45 2.45 2.45 2.45 2.29 2.29 2.29 2.29 2.21 2.21 2.21 2.21 2.24 2.24 2.24 2.24 2.31 2.31 2.31 2.307
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-0.43 $0.40 $0.57 $0.70 $0.64 $0.74 $0.79 $0.70 $0.58 $0.95 $1.10 $1.02 $0.83 $-1.17 $-1.16 $-0.82 $-3.19 $-1.68 $-1.60 $-1.97 $-1.97
Book Value/Share $10.94 $11.11 $11.01 $11.45 $11.93 $13.04 $13.14 $13.17 $10.58 $11.24 $13.98 $13.78 $13.78 $13.12 $13.02 $10.45 $12.89 $11.31 $11.17 $11.28 $11.65
Tangible Book/Share $2.21 $3.23 $3.20 $3.33 $3.47 $5.26 $5.30 $5.32 $4.27 $5.09 $6.33 $6.23 $6.23 $5.59 $5.55 $4.45 $5.49 $6.22 $6.15 $6.21 $6.21
Revenue/Share $18.45 $18.81 $19.13 $20.17 $21.09 $21.01 $21.33 $21.72 $17.81 $17.69 $21.62 $20.77 $20.21 $19.88 $19.97 $16.16 $19.79 $20.21 $20.20 $20.47 $20.47
FCF/Share $0.33 $1.78 $1.86 $1.43 $0.90 $-0.11 $-0.50 $0.32 $1.06 $1.74 $2.38 $1.76 $1.02 $0.50 $0.63 $0.75 $0.88 $0.45 $-0.31 $-0.74 $-0.74
OCF/Share $0.73 $2.13 $2.19 $1.78 $1.24 $0.41 $0.06 $0.94 $1.56 $2.15 $3.01 $2.38 $1.66 $1.16 $1.13 $1.17 $1.44 $1.00 $0.38 $-0.05 $-0.05
Cash/Share $2.44 $3.32 $3.29 $3.43 $3.57 $2.19 $2.20 $2.21 $1.77 $3.84 $4.78 $4.71 $4.71 $4.91 $4.88 $3.92 $4.83 $3.71 $3.67 $3.70 $2.11
EBITDA/Share $1.57 $2.48 $2.62 $2.93 $2.96 $2.80 $2.80 $2.58 $2.11 $1.81 $2.10 $1.93 $1.47 $1.50 $1.58 $1.48 $-0.21 $0.08 $0.18 $0.02 $0.02
Debt/Share $11.73 $10.56 $10.46 $10.89 $11.34 $10.67 $10.75 $10.78 $8.66 $9.30 $11.57 $11.40 $11.40 $11.53 $11.45 $9.19 $11.33 $9.61 $9.50 $9.59 $9.59
Net Debt/Share $9.30 $7.24 $7.17 $7.46 $7.77 $8.48 $8.55 $8.57 $6.88 $5.46 $6.80 $6.70 $6.70 $6.62 $6.57 $5.27 $6.50 $5.90 $5.83 $5.89 $5.89
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score 1.607
Altman Z-Prime snapshot only 3.261
Piotroski F-Score 6 8 8 8 8 7 7 7 7 8 7 7 7 3 3 3 3 5 4 4 4
Beneish M-Score -3.01 -2.59 -2.55 -2.44 -2.35 -2.31 -2.23 -2.46 -2.57 -2.80 -2.83 -2.75 -2.67 -2.91 -2.97 -2.98 -3.30 -3.07 -2.92 -2.92 -2.916
Ohlson O-Score snapshot only -6.343
ROIC (Greenblatt) snapshot only -4.07%
Net-Net WC snapshot only $0.50
EVA snapshot only $-96667000.00
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only B
Credit Score 37.13 47.68 51.85 53.27 52.62 50.15 51.97 50.32 57.91 53.17 53.11 51.65 44.06 38.30 45.54 39.50 42.31 31.90 29.43 27.86 27.863
Credit Grade snapshot only 15
Credit Trend snapshot only -11.633
Implied Spread (bps) snapshot only 750.000
Industry Credit Rank snapshot only 20
Sector Credit Rank snapshot only 8

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms